Phosphatidylcholine as a potential Alzheimer's-related biomarker in Down syndrome, but not in Alzheimer's disease patients: Preliminary findings

This study investigates phosphatidylcholine as a potential biomarker for Alzheimer's disease-related pathology in Down syndrome individuals, finding differential patterns compared to traditional Alzheimer's disease patients. The preliminary results suggest distinct biochemical signatures between these populations regarding AD-related processes.